We would love to hear your thoughts about our site and services, please take our survey here.
No need for that - they've just raised 12 million at a small discount, but that's not something that needs talking about here. Let's see what Trx can do to complete the 1.6 million they were going to raise by this time 2 years ago. Keep it relevant.
PP - that'll be 'Dr Dilly's upbeat assessment' which you agree is 'blindingly obvious' is not worth the breath it is spoken with.
As a cautionary note, it is worth keeping it firmly in mind that SD can say all sort of things on the lines of hoping for a 'blockbuster year', expecting to put out a 'significant update' on any products at all, and all sorts of comments could be made on the lines of 'hop', 'expect', 'anticipate', 'looking towards' etc etc - All the comments mean is they are an aspiration at best, and more likely just a fluffy platitude. Any actual facts which may have a material effect on the company's share price will be issued via RNS. Remember Sareum several years ago stated confidently that they expected to conclude 'at least two commercial deals by the end of the year.' It was a comment, not in an RNS, and it was an expectation. Guess what? Nothing happened. So SD could say 'I expect Val will be a multi billion dollar company in 3 years', 'I expect the lab to generate enormous income by the end of Q1' or 'I hope a major bio will buy buy us out for 100 billion' and not break any rules at all. It would get a lot of underwear here very moist, but it would mean absolutely zilch as it wasn't official news, it would just undermine her credibility. The only financial things RNSed lately have been a small amount of now-completed work several months ago at the lab, and the acceptance of a tiny amount of shares in a very small company in return for a contract which may or may not lead to possible further interest in a year or so, with no figures given for either. And that's it. What happens next I won't forecast, but wheat and chaff need separating, and so far it's pretty much chaff as far as I can see.
Castor - 'Im sure there will be no problem for us to go on NASDAQ.'
That has to be the funniest thing I've read here in a very long time. But be careful with the tongue in cheek comments, some other posters might get upset.
If another party were interested in ValiRx I don't think the BoD would have clung to Trx and made excuses for their inability to produce any money at all in 2 years.
As far as I remember, the mythical 'Black Cat Bio' are still trying to raise 5 million in total silence for a good few years. Correct me if I'm wrong...
The figures are all in the RNSs.
'Company will receive gross proceeds of approximately £12.7 million.' That's including 2m from the PI open offer, assuming it is fully subscribed.
More fool VAL for giving exclusivity to Trx. Was this because they honestly thought that an unknown outfit could source 1.6 million in about six weeks/six months/2 years/whatever? Or was it a means of disguising the fact that nobody else was even remotely interested in Val? Have they been turning down hordes of funding approaches saying 'sorry, we're in an exclusive agreement with Trx'? Without the LOI story I suspect it would have been just total silence, which is as good as what they have got to date.
CastorTroy
Posts: 98
Price: 7.80
No Opinion
No News Is GREAT NEWS!Today 08:55
Im 100% with P.I.
REVERSAL DAY!
Which way...?
Https://x.com/scancellpharma/status/1733117393583444374?s=20
I thought it was that they didn't have authority to place spontaneously, but a placing can be put to an EGM for approval or otherwise by shareholders?
Paternoster - No, I was referring to VAL, that's why I posted on the VAL board. Since you mention them, you are probably aware that sclp have just raised 12 million at about 5 percent discount, to add to 20 million in the bank, and an 85 percent orr in stage 4 cancer patients and a number of institutional investors. But that's not relevant to VAL's predicament is it? So maybe stick with me deciding whether VAL is investable or not. Keep focused.
It's looking like a late afternoon RNS tomorrow. Around 4.29pm. I would hope not, for the sake of so many here, but we shall see.
That very much depends on the company you keep. With all due respect Fred.
Just a couple of small but significant details need adding to your last - "Surely Inophea is generating some decent revenue now" - surely Suzy would have mentioned that in the video the other day if it were even on the horizon?
And as for 'The 201 money will come in handy' - with all due respect, what 201 money? Seem to be a few large 'IF's missing there.
Given that a placing at 11p hasn't been fully finished, and the open offer to shareholders hasn't even had the paperwork sent out yet, the sp reaction is very encouraging with some regular 100k buys cropping up along the way. Just goes to show that a healthy cash balance says a great deal. Back it with VERY promising trial results and the future looks quite interesting. Imo....
The fact remains that today's RNS provides no cash of any significance whatsoever, so the question remains 'where is the urgently needed money coming from?'
Is the next RNS a shed load of cash from TheoremRx or a placing with Suzy saying 'we are very disappointed that euda/TheoremRx merger hasn't worked in our favour, and this placing is essential to provide working capital (i.e. salaries for the bod) until the 401 "deal" bears fruit.'
Place your bets....
I'm pretty sure I will.
Maybe, but you could also argue that as the man who didn't invest 100k and as a consequence still have it, that also says a lot.
I'm not suggesting anyone invest, not invest, buy more or sell up on anything other than their own research, but the greater the percentage of one's wealth you invest, the more rigorously and dispassionately you should research, i would suggest. I'm just exploring facts versus conjecture.
As far as 'the professor' is concerned, anyone who is into Val for a seven figure sum is surely trapped and unable to get out without crashing the share price and their own remaining investment as a consequence. And it also depends what fraction of one's fortune a million quid might be. For me, 100k is a maximum in one company, but for others a million may be an amount they'd be happy to lose or take a big hit on.
As ever, just putting out food for thought - not something to be scared of, although it will say a lot about attitudes and fear if this post is still here by 9am tomorrow.
It's a matter of looking for a business case on which to invest - I've been watching for years, and had I invested 100k before the last consolidation it would have become 800 quid, so I would suggest that my intuition has saved me 96,400 pounds, wouldn't you?
Believe me, I'm not 'saving you' from anything. I watched John Gilchrist post here and thought he was a little blinkered, then as I understand it he took his own life as a consequence (correct me if I'm wrong) - if that were the case, I'd like to think I am a little more prudent before pitching in wholesale.
As for 'the statement from EUDA clearly indicates that they felt TRX has access to significant funds. No IFS to that statement. RNS also confirms Valirx would get paid when the sub license is signed. I think everyone knows that.'
Look closely at what you yourself say - 'EUDA....indicates...they felt', and 'when the sub licence is signed'....When? You mean 'if', or 'assuming.'
This is very much about business.
It's not science, it's business. Everything hangs on numerous interconnected 'ifs.' Should one 'if' fail, the whole thing collapses like a house of cards.
You say 'TRX obviously sees significant potential in 201 to be funding 10s million for trials as and when it is confirmed' - but theoremrx aren't funding '10s of millions', they're trying and so far failing for 2 years to raise under 2 million. And it isn't 'when it is confirmed', it's IF. And that 'IF' has looked ever larger and more shaky as time passes, hasn't it?